Core Viewpoint - The company has announced its 2025 semi-annual profit distribution plan, which includes a capital reserve increase of 4.5 shares for every 10 shares held, resulting in an increase in total share capital from 288 million to 417.6 million shares [1][2]. Group 1: Profit Distribution Plan - The profit distribution plan was approved at the shareholder meeting held on August 18, 2025, allowing for a capital reserve increase of 4.5 shares for every 10 shares held [1][2]. - The total share capital will increase from 288 million shares to 417.6 million shares following the distribution [2]. Group 2: Shareholder Information - The distribution will be applicable to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, as of the close of trading on August 26, 2025 [2]. - The shares will be credited to shareholders' accounts on August 27, 2025, with fractional shares being allocated based on a specific sorting method [2]. Group 3: Share Capital Changes - The company will adjust the total share capital based on the number of shares on the record date if there are changes due to convertible bonds, share buybacks, or other reasons [1][2]. - The adjusted minimum selling price for shares after the distribution will be set at 13.92 yuan per share [4].
亨迪药业: 2025年半年度利润分配实施公告